-
Mashup Score: 3Anti-Xa Levels in Morbidly Obese Patients Using Apixaban or Rivaroxaban, Before and After Bariatric Surgery - PubMed - 2 year(s) ago
Plasma anti-Xa levels of apixaban in MO patients remained within the therapeutic range up to a body weight of 144 kg. In patients using rivaroxaban, no statistically significant relation between anti-Xa levels and bodyweight was found. After RYGB, plasma anti-Xa levels of apixaban were unaffected, w …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Anti-Xa activity and hemorrhagic events under extracorporeal membrane oxygenation (ECMO): a multicenter cohort study - 3 year(s) ago
Background Hemorrhagic events remain a major concern in patients under extracorporeal membrane oxygenation (ECMO) support. We tested the association between anticoagulation levels and hemorrhagic events under ECMO using anti-Xa activity monitoring. Methods We performed a retrospective multicenter cohort study in three ECMO centers. All adult patients treated with veno-venous (VV)- or…
Source: Critical CareCategories: Critical Care, Latest HeadlinesTweet
#Anti_Xa Levels in Morbidly #Obese Using #Apixaban or #Rivaroxaban, Before and After #Bariatric_Surgery https://t.co/Ijhohn1A7g